Report Detail
Global Epigenetics Drugs and Diagnostic Technologies Market Professional Survey Report 2019
- RnM3721416 |
- 03 September, 2019 |
- Global |
- 120 Pages |
- QYResearch |
- Pharma & Healthcare
The drugs and technologies that treat the reletive diseases
Rising incidence of gene expression changes due to chemical modifications in DNA or chromatin is the major factor driving the growth of epigenetics drugs and diagnostic technologies market
Increasing demand for epigenetics drugs and diagnostic technology is a direct consequence of rapidly increasing incidences of oncological disorders
The global Epigenetics Drugs and Diagnostic Technologies market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Epigenetics Drugs and Diagnostic Technologies volume and value at global level, regional level and company level. From a global perspective, this report represents overall Epigenetics Drugs and Diagnostic Technologies market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Epigenetics Drugs and Diagnostic Technologies in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Epigenetics Drugs and Diagnostic Technologies manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Varlix Plc
Topotarget
Syndax Pharmaceuticals
Spectrum Pharmaceuticals
Promega
Novartis
Oncolys BioPharma
MDxHealth
Merck
Illumina
Epizyme
Forum Pharmaceuticals
EpiGentek
Chroma Therapeutics
Celleron Therapeutics
CellCentric
Astex Pharmaceuticals
Acetylon Pharmaceuticals
4SC AG
Eisai
Pharmacyclics
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
HDAC inhibitors
DNMT inhibitors
Segment by Application
Non coding RNA’s
Micro RNA’s
Histone modifications
DNA methylation
Table of Contents
Executive Summary
1 Industry Overview of Epigenetics Drugs and Diagnostic Technologies
- 1.1 Definition of Epigenetics Drugs and Diagnostic Technologies
- 1.2 Epigenetics Drugs and Diagnostic Technologies Segment by Type
- 1.2.1 Global Epigenetics Drugs and Diagnostic Technologies Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 HDAC inhibitors
- 1.2.3 DNMT inhibitors
- 1.3 Epigenetics Drugs and Diagnostic Technologies Segment by Applications
- 1.3.1 Global Epigenetics Drugs and Diagnostic Technologies Consumption Comparison by Applications (2014-2025)
- 1.3.2 Non coding RNA’s
- 1.3.3 Micro RNA’s
- 1.3.4 Histone modifications
- 1.3.5 DNA methylation
- 1.4 Global Epigenetics Drugs and Diagnostic Technologies Overall Market
- 1.4.1 Global Epigenetics Drugs and Diagnostic Technologies Revenue (2014-2025)
- 1.4.2 Global Epigenetics Drugs and Diagnostic Technologies Production (2014-2025)
- 1.4.3 North America Epigenetics Drugs and Diagnostic Technologies Status and Prospect (2014-2025)
- 1.4.4 Europe Epigenetics Drugs and Diagnostic Technologies Status and Prospect (2014-2025)
- 1.4.5 China Epigenetics Drugs and Diagnostic Technologies Status and Prospect (2014-2025)
- 1.4.6 Japan Epigenetics Drugs and Diagnostic Technologies Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Epigenetics Drugs and Diagnostic Technologies Status and Prospect (2014-2025)
- 1.4.8 India Epigenetics Drugs and Diagnostic Technologies Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Epigenetics Drugs and Diagnostic Technologies
- 2.3 Manufacturing Process Analysis of Epigenetics Drugs and Diagnostic Technologies
- 2.4 Industry Chain Structure of Epigenetics Drugs and Diagnostic Technologies
3 Development and Manufacturing Plants Analysis of Epigenetics Drugs and Diagnostic Technologies
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Epigenetics Drugs and Diagnostic Technologies Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Epigenetics Drugs and Diagnostic Technologies
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Epigenetics Drugs and Diagnostic Technologies Production and Capacity Analysis
- 4.2 Epigenetics Drugs and Diagnostic Technologies Revenue Analysis
- 4.3 Epigenetics Drugs and Diagnostic Technologies Price Analysis
- 4.4 Market Concentration Degree
5 Epigenetics Drugs and Diagnostic Technologies Regional Market Analysis
- 5.1 Epigenetics Drugs and Diagnostic Technologies Production by Regions
- 5.1.1 Global Epigenetics Drugs and Diagnostic Technologies Production by Regions
- 5.1.2 Global Epigenetics Drugs and Diagnostic Technologies Revenue by Regions
- 5.2 Epigenetics Drugs and Diagnostic Technologies Consumption by Regions
- 5.3 North America Epigenetics Drugs and Diagnostic Technologies Market Analysis
- 5.3.1 North America Epigenetics Drugs and Diagnostic Technologies Production
- 5.3.2 North America Epigenetics Drugs and Diagnostic Technologies Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Epigenetics Drugs and Diagnostic Technologies Import and Export
- 5.4 Europe Epigenetics Drugs and Diagnostic Technologies Market Analysis
- 5.4.1 Europe Epigenetics Drugs and Diagnostic Technologies Production
- 5.4.2 Europe Epigenetics Drugs and Diagnostic Technologies Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Epigenetics Drugs and Diagnostic Technologies Import and Export
- 5.5 China Epigenetics Drugs and Diagnostic Technologies Market Analysis
- 5.5.1 China Epigenetics Drugs and Diagnostic Technologies Production
- 5.5.2 China Epigenetics Drugs and Diagnostic Technologies Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Epigenetics Drugs and Diagnostic Technologies Import and Export
- 5.6 Japan Epigenetics Drugs and Diagnostic Technologies Market Analysis
- 5.6.1 Japan Epigenetics Drugs and Diagnostic Technologies Production
- 5.6.2 Japan Epigenetics Drugs and Diagnostic Technologies Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Epigenetics Drugs and Diagnostic Technologies Import and Export
- 5.7 Southeast Asia Epigenetics Drugs and Diagnostic Technologies Market Analysis
- 5.7.1 Southeast Asia Epigenetics Drugs and Diagnostic Technologies Production
- 5.7.2 Southeast Asia Epigenetics Drugs and Diagnostic Technologies Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Epigenetics Drugs and Diagnostic Technologies Import and Export
- 5.8 India Epigenetics Drugs and Diagnostic Technologies Market Analysis
- 5.8.1 India Epigenetics Drugs and Diagnostic Technologies Production
- 5.8.2 India Epigenetics Drugs and Diagnostic Technologies Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Epigenetics Drugs and Diagnostic Technologies Import and Export
6 Epigenetics Drugs and Diagnostic Technologies Segment Market Analysis (by Type)
- 6.1 Global Epigenetics Drugs and Diagnostic Technologies Production by Type
- 6.2 Global Epigenetics Drugs and Diagnostic Technologies Revenue by Type
- 6.3 Epigenetics Drugs and Diagnostic Technologies Price by Type
7 Epigenetics Drugs and Diagnostic Technologies Segment Market Analysis (by Application)
- 7.1 Global Epigenetics Drugs and Diagnostic Technologies Consumption by Application
- 7.2 Global Epigenetics Drugs and Diagnostic Technologies Consumption Market Share by Application (2014-2019)
8 Epigenetics Drugs and Diagnostic Technologies Major Manufacturers Analysis
- 8.1 Varlix Plc
- 8.1.1 Varlix Plc Epigenetics Drugs and Diagnostic Technologies Production Sites and Area Served
- 8.1.2 Varlix Plc Product Introduction, Application and Specification
- 8.1.3 Varlix Plc Epigenetics Drugs and Diagnostic Technologies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Topotarget
- 8.2.1 Topotarget Epigenetics Drugs and Diagnostic Technologies Production Sites and Area Served
- 8.2.2 Topotarget Product Introduction, Application and Specification
- 8.2.3 Topotarget Epigenetics Drugs and Diagnostic Technologies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Syndax Pharmaceuticals
- 8.3.1 Syndax Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Production Sites and Area Served
- 8.3.2 Syndax Pharmaceuticals Product Introduction, Application and Specification
- 8.3.3 Syndax Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Spectrum Pharmaceuticals
- 8.4.1 Spectrum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Production Sites and Area Served
- 8.4.2 Spectrum Pharmaceuticals Product Introduction, Application and Specification
- 8.4.3 Spectrum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Promega
- 8.5.1 Promega Epigenetics Drugs and Diagnostic Technologies Production Sites and Area Served
- 8.5.2 Promega Product Introduction, Application and Specification
- 8.5.3 Promega Epigenetics Drugs and Diagnostic Technologies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Novartis
- 8.6.1 Novartis Epigenetics Drugs and Diagnostic Technologies Production Sites and Area Served
- 8.6.2 Novartis Product Introduction, Application and Specification
- 8.6.3 Novartis Epigenetics Drugs and Diagnostic Technologies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Oncolys BioPharma
- 8.7.1 Oncolys BioPharma Epigenetics Drugs and Diagnostic Technologies Production Sites and Area Served
- 8.7.2 Oncolys BioPharma Product Introduction, Application and Specification
- 8.7.3 Oncolys BioPharma Epigenetics Drugs and Diagnostic Technologies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 MDxHealth
- 8.8.1 MDxHealth Epigenetics Drugs and Diagnostic Technologies Production Sites and Area Served
- 8.8.2 MDxHealth Product Introduction, Application and Specification
- 8.8.3 MDxHealth Epigenetics Drugs and Diagnostic Technologies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Merck
- 8.9.1 Merck Epigenetics Drugs and Diagnostic Technologies Production Sites and Area Served
- 8.9.2 Merck Product Introduction, Application and Specification
- 8.9.3 Merck Epigenetics Drugs and Diagnostic Technologies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Illumina
- 8.10.1 Illumina Epigenetics Drugs and Diagnostic Technologies Production Sites and Area Served
- 8.10.2 Illumina Product Introduction, Application and Specification
- 8.10.3 Illumina Epigenetics Drugs and Diagnostic Technologies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Epizyme
- 8.12 Forum Pharmaceuticals
- 8.13 EpiGentek
- 8.14 Chroma Therapeutics
- 8.15 Celleron Therapeutics
- 8.16 CellCentric
- 8.17 Astex Pharmaceuticals
- 8.18 Acetylon Pharmaceuticals
- 8.19 4SC AG
- 8.20 Eisai
- 8.21 Pharmacyclics
9 Development Trend of Analysis of Epigenetics Drugs and Diagnostic Technologies Market
- 9.1 Global Epigenetics Drugs and Diagnostic Technologies Market Trend Analysis
- 9.1.1 Global Epigenetics Drugs and Diagnostic Technologies Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Epigenetics Drugs and Diagnostic Technologies Regional Market Trend
- 9.2.1 North America Epigenetics Drugs and Diagnostic Technologies Forecast 2019-2025
- 9.2.2 Europe Epigenetics Drugs and Diagnostic Technologies Forecast 2019-2025
- 9.2.3 China Epigenetics Drugs and Diagnostic Technologies Forecast 2019-2025
- 9.2.4 Japan Epigenetics Drugs and Diagnostic Technologies Forecast 2019-2025
- 9.2.5 Southeast Asia Epigenetics Drugs and Diagnostic Technologies Forecast 2019-2025
- 9.2.6 India Epigenetics Drugs and Diagnostic Technologies Forecast 2019-2025
- 9.3 Epigenetics Drugs and Diagnostic Technologies Market Trend (Product Type)
- 9.4 Epigenetics Drugs and Diagnostic Technologies Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Epigenetics Drugs and Diagnostic Technologies Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Epigenetics Drugs and Diagnostic Technologies. Industry analysis & Market Report on Epigenetics Drugs and Diagnostic Technologies is a syndicated market report, published as Global Epigenetics Drugs and Diagnostic Technologies Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Epigenetics Drugs and Diagnostic Technologies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
